Inventor · disambiguated record
Manfred Motz
Also filed as: MOTZ MANFRED
16 granted patents·2 pending applications·107 citations·filing 1991–2016
93Inventor score
Files withMIKROGEN MOLEKULARBIOL ENTW8ROCHE DIAGNOSTICS GMBH5BAUER GEORG1MIKROGEN MOLEKULARBIOGISCHE EN1SEIDEL CHRISTOPH1
Top patents by PatentIndex Score
18 records- 0176US6808711B2Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccinesMIKROGEN MOLEKULARBIOL ENTW·Filed 2003·Granted Oct 26, 2004·5 cites·8 claims
- 0275US6306579B1Recombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Oct 23, 2001·24 cites·17 claims
- 0375US6270960B1Recombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 2000·Granted Aug 7, 2001·5 cites·15 claims
- 0471US6096319ARecombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 1995·Granted Aug 1, 2000·19 cites·9 claims
- 0567US7083792B2Immunologically active proteins from Borrelia burgdorferiMIKROGEN MOLEKULARBIOL ENTW·Filed 2004·Granted Aug 1, 2006·1 cites·4 claims
- 0667US6509019B1Immunologically active proteins from Borrelia burgdorferiMIKROGEN MOLEKULARBIOL ENTW·Filed 2000·Granted Jan 21, 2003·1 cites·5 claims
- 0765US7122302B2Method for determining early HCV seroconversionROCHE DIAGNOSTICS GMBH·Filed 2001·Granted Oct 17, 2006·1 cites·9 claims
- 0865US6274307B1Immunologically active peptides or polypeptides from the parvovirus B19MIKROGEN MOLEKULARBIOL ENTW·Filed 1997·Granted Aug 14, 2001·16 cites·20 claims
- 0964US6610301B1Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccinesMIKROGEN MOLEKULARBIOL ENTW·Filed 1997·Granted Aug 26, 2003·23 cites·17 claims
- 1062US2009098528A1Method for determining early HCV seroconversionSEIDEL CHRISTOPH·Filed 2007·Application pending·0 cites
- 1157US6753183B2Immunologically active proteins from Borrelia burgdorferiMIKROGEN MOLEKULARBIOL ENTW·Filed 2002·Granted Jun 22, 2004·0 cites·9 claims
- 1257US2005095584A1Method for determining early HCV seroconversionFiled 2004·Application pending·0 cites
- 1346US10669350B2Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapyBAUER GEORG·Filed 2016·Granted Jun 2, 2020·0 cites·10 claims
- 1445US7476498B2Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereofMIKROGEN MOLEKULARBIOL ENTW·Filed 2005·Granted Jan 13, 2009·0 cites·2 claims
- 1536US6183755B1Active proteins from Borrelia burgdorferiMIKROGEN MOLEKULARBIOL ENTW·Filed 1998·Granted Feb 6, 2001·3 cites·5 claims
- 1634US6136527APolypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C virusesROCHE DIAGNOSTICS GMBH·Filed 1991·Granted Oct 24, 2000·3 cites·13 claims
- 1732US5741656AEpstein-Barr virus sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic testsWOLF HANS JOACHIM·Filed 1994·Granted Apr 21, 1998·2 cites·6 claims
- 1831US6248538B1Immunologically active PC proteins from Borrelia burgdorferiMIKROGEN MOLEKULARBIOGISCHE EN·Filed 1994·Granted Jun 19, 2001·4 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →